ATE265685T1 - Verbesserter blutgerinnungstest - Google Patents

Verbesserter blutgerinnungstest

Info

Publication number
ATE265685T1
ATE265685T1 AT99903537T AT99903537T ATE265685T1 AT E265685 T1 ATE265685 T1 AT E265685T1 AT 99903537 T AT99903537 T AT 99903537T AT 99903537 T AT99903537 T AT 99903537T AT E265685 T1 ATE265685 T1 AT E265685T1
Authority
AT
Austria
Prior art keywords
plasma sample
coagulation
reagent
factor
protein
Prior art date
Application number
AT99903537T
Other languages
English (en)
Inventor
Thomas Exner
Original Assignee
Gradipore Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gradipore Ltd filed Critical Gradipore Ltd
Application granted granted Critical
Publication of ATE265685T1 publication Critical patent/ATE265685T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/4609Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates from reptiles
    • G01N2333/4613Snake venom
    • G01N2333/462Snake venom from Agkistrodon sp., e.g. acutase, ACTE

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
AT99903537T 1998-02-02 1999-02-01 Verbesserter blutgerinnungstest ATE265685T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP1596A AUPP159698A0 (en) 1998-02-02 1998-02-02 Improved blood coagulation test
PCT/AU1999/000069 WO1999039212A1 (en) 1998-02-02 1999-02-01 Improved blood coagulation test

Publications (1)

Publication Number Publication Date
ATE265685T1 true ATE265685T1 (de) 2004-05-15

Family

ID=3805873

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99903537T ATE265685T1 (de) 1998-02-02 1999-02-01 Verbesserter blutgerinnungstest

Country Status (9)

Country Link
US (1) US6838251B1 (de)
EP (1) EP1068536B1 (de)
JP (1) JP4331891B2 (de)
AT (1) ATE265685T1 (de)
AU (1) AUPP159698A0 (de)
CA (1) CA2318250A1 (de)
DE (1) DE69916816T2 (de)
ES (1) ES2217739T3 (de)
WO (1) WO1999039212A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2162361T3 (es) * 1998-03-19 2001-12-16 Instrumentation Lab Spa Metodos, kits y reactivos mejorados para el muestreo de defectos de la coagulacion sanguinea.
EP1367135A1 (de) 2002-05-29 2003-12-03 Pentapharm AG Verbessertes Verfahren zur Beurteilung der Thrombinbildung in Blutplasma
US7245215B2 (en) * 2005-02-10 2007-07-17 Pinc Solutions Position-tracking device for position-tracking system
CN102692511B (zh) * 2012-06-08 2015-04-15 上海太阳生物技术有限公司 蛋白c(pc)测定试剂盒(发色底物法)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3607559A1 (de) 1986-03-07 1987-09-10 Boehringer Mannheim Gmbh Verfahren zur photometrischen bestimmung der protein c- und/oder protein s-aktivitaet
DE3724443A1 (de) 1987-07-23 1989-02-02 Max Planck Gesellschaft Funktioneller test zur bestimmung der protein s-aktivitaet
SE464135B (sv) * 1989-07-14 1991-03-11 Kabivitrum Ab Foerfarande foer bestaemning av funktionell aktivitet av fritt protein s eller protein c i ett plasmaprov
US5601995A (en) * 1992-09-04 1997-02-11 Gradipore Limited Apparatus and method for detecting coagulation in blood samples
DE59410041D1 (de) * 1993-12-03 2002-03-21 Baxter Ag Test zur Bestimmung der Empfindlichkeit gegenüber aktiviertem Protein C
AUPM731394A0 (en) * 1994-08-05 1994-09-01 Life Therapeutics Limited Improved activated protein c resistance test
DE4427785A1 (de) * 1994-08-08 1996-02-15 Behringwerke Ag Verfahren zum Nachweis von Störungen des Protein C/Protein S-Systems
US5780255A (en) * 1995-06-09 1998-07-14 Instrumentation Laboratory, S.P.A. Protein C pathway screening test
FR2764389B1 (fr) * 1997-06-06 1999-08-06 Stago Diagnostica Utilisation de venin de crotalus viridis helleri, procede et necessaire pour la determination de la reactivite de la proteine c activee

Also Published As

Publication number Publication date
EP1068536A4 (de) 2002-09-04
WO1999039212A1 (en) 1999-08-05
JP2002502040A (ja) 2002-01-22
CA2318250A1 (en) 1999-08-05
AUPP159698A0 (en) 1998-02-26
JP4331891B2 (ja) 2009-09-16
DE69916816D1 (de) 2004-06-03
EP1068536B1 (de) 2004-04-28
DE69916816T2 (de) 2004-09-30
EP1068536A1 (de) 2001-01-17
ES2217739T3 (es) 2004-11-01
US6838251B1 (en) 2005-01-04

Similar Documents

Publication Publication Date Title
Lange et al. Ecarin chromogenic assay–a new method for quantitative determination of direct thrombin inhibitors like hirudin
CA2252983C (en) Method for determining the anticoagulatory potential of a sample
He et al. A laboratory method for determination of overall haemostatic potential in plasma. I. Method design and preliminary results
JP4762472B2 (ja) 血液学的アッセイ及び試薬
US20090087870A1 (en) Hematological assay and kit
DE69021849D1 (de) Verfahren zur Bestimmung des Spiegels von exogenen und endogenen Gerinnungsfaktoren und von Protein C.
ATE311601T1 (de) Rekombinant-kaninchengewebefaktor basiertes prothrombinzeitreagenz
JPH11225796A5 (de)
CA2080407A1 (en) Functional test and reagent for determining fibrinogen (case hoe 91/b 032- ma 926)
Lindhoff-Last et al. Hirudin Determination in Plasma Can Be Strongly Influenced by the Prothrombin Level☆
AU1538202A (en) A reagent and kit for determining global coagulability and hemostatic potential
DE69916816D1 (de) Verbesserter blutgerinnungstest
Hedner et al. Inhibition of activated haceman factor (factor XIIa) by an inhibitor of the plasminogen activation (PA inhibitor)
Toulon et al. Screening for abnormalities of the protein C anticoagulant pathway using the ProC Global assay. Results of a European multicenter evaluation
Kher et al. Laboratory assessment of antithrombotic therapy: what tests and if so why?
Antovic et al. Does recombinant factor VIIa, apart from overall hemostasis, regulate TAFI dependent fibrinolysis? In vitro analysis using overall hemostasis potential (OHP) assay
US5753510A (en) Calibrator for use in test methods for detecting a defective coagulation factor V
van de Waart et al. A functional test for protein S activity in plasma
Eichinger Thrombin generation and venous thromboembolism
GB2368642A (en) Method for detecting, treating, and monitoring conditions associated with activation of the coagulation response
Kobayashi et al. Amidolytic kinetic assay of protein C by selective spectrophotometry in a centrifugal analyzer.
Demir et al. Ecarin clotting time is sensitive to heparinoids: comparison of two different techniques
WO2025186634A8 (en) Method and kit for monitoring anticoagulant therapy
Paladino et al. Laboratory Aspects
Mann et al. Thrombin generation in a reconstituted system: A reply

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
EEWE Authorization for restitution
UEP Publication of translation of european patent specification

Ref document number: 1068536

Country of ref document: EP

REN Ceased due to non-payment of the annual fee